Kern A, Bader A, Pichlmayr R, Sewing K F
Drug Metabolism, Bayer AG, Wuppertal, Germany.
Biochem Pharmacol. 1997 Oct 1;54(7):761-72. doi: 10.1016/s0006-2952(97)00204-9.
Adult hepatocytes from rat and man were maintained for 2 weeks between two gel layers in a sandwich configuration to study the influence of this culture technique on the preservation of basal activities of xenobiotic-metabolizing phase I and phase II enzymes. The response of these enzyme activities to an enzyme inducer was investigated using rifampicin (RIF). Basal levels of cytochrome P-450 (CYP) isozymes were characterized by measuring ethoxyresorufin O-deethylation (EROD), ethoxycoumarin O-deethylation (ECOD), and the specific oxidation of testosterone (T). In hepatocytes from untreated rats, CYP isozyme levels, including the major form CYP 2C11, increased during the first 3 days in culture. After this period of recovery, the levels of CYP 2C11, CYP 2A1, and CYP 2B1 decreased, whereas CYP 3A1 increased. In contrast to these dynamic changes, CYP activities such as CYP 1A2 and the major isozyme CYP 3A4 were largely preserved until day 9 in cultures of human hepatocytes. In measuring phase II activities, a distinct increase in glucuronosyltransferase (UDP-GT) activity toward p-nitrophenol (PNP) was found for rat and human hepatocytes over 2 weeks in culture. Sulfotransferase (ST) activity toward PNP showed an initial increase, with a maximum at day 7 and day 9 in culture, respectively, and then decreased until day 14. Glutathione S-transferase (GST) activity decreased constantly during the time of culture. Effects of the enzyme-inducing drug rifampicin on phase I and phase II enzymes were investigated using cultured human hepatocytes. Rifampicin treatment (50 micromol/L) for 7 days resulted in a 3.7-fold induction of CYP 3A4 at day 9 in culture. ECOD activity was increased sixfold and phase II ST activity increased twofold compared to the initial value at day 3. No effect of rifampicin on CYP 3A was found in cultures of rat hepatocytes. These results demonstrate that rat and human hepatocytes preserve the major forms of CYP isozymes and phase II activities and respond to inducing drugs such as rifampicin. The novel hepatocyte sandwich culture is suitable for investigating drug metabolism, drug-drug interactions and enzyme induction.
将大鼠和人的成年肝细胞以夹心结构培养在两层凝胶之间两周,以研究这种培养技术对异生物代谢I相和II相酶基础活性保存的影响。使用利福平(RIF)研究这些酶活性对酶诱导剂的反应。通过测量乙氧异吩恶唑酮O-脱乙基酶(EROD)、乙氧香豆素O-脱乙基酶(ECOD)和睾酮(T)的特异性氧化来表征细胞色素P-450(CYP)同工酶的基础水平。在未处理大鼠的肝细胞中,包括主要形式CYP 2C11在内的CYP同工酶水平在培养的前3天增加。在这段恢复时期之后,CYP 2C11、CYP 2A1和CYP 2B1的水平下降,而CYP 3A1增加。与这些动态变化相反,在人肝细胞培养物中,直到第9天,CYP 1A2和主要同工酶CYP 3A4等CYP活性在很大程度上得以保留。在测量II相活性时,发现大鼠和人肝细胞在培养2周期间对对硝基苯酚(PNP)的葡萄糖醛酸基转移酶(UDP-GT)活性有明显增加。对PNP的磺基转移酶(ST)活性最初增加,分别在培养的第7天和第9天达到最大值,然后下降直到第14天。谷胱甘肽S-转移酶(GST)活性在培养期间持续下降。使用培养的人肝细胞研究了酶诱导药物利福平对I相和II相酶的影响。在培养第9天,用50微摩尔/升利福平处理7天导致CYP 3A4诱导3.7倍。与第3天初始值相比,ECOD活性增加了6倍,II相ST活性增加了2倍。在大鼠肝细胞培养物中未发现利福平对CYP 3A有影响。这些结果表明大鼠和人肝细胞保留了CYP同工酶的主要形式和II相活性,并对利福平等诱导药物有反应。这种新型的肝细胞夹心培养适用于研究药物代谢、药物-药物相互作用和酶诱导。